Why Providers Are Turning to KEFUNOVA™, a new 5-FU and Calcipotriene Combination for Actinic Keratosis and Superficial Basal Cell Carcinoma Patients
/*! elementor – v3.23.0 – 05-08-2024 */.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} SKNV Rx Insights Why Providers Are Turning to KEFUNOVA™, a new 5-FU and Calcipotriene Combination for Actinic Keratosis and Superficial Basal Cell Carcinoma Patients 5 FU: Effective Treatment for Actinic Keratosis and Skin Conditions By Nathalie De Champlain Millions of Americans* annually […]
The Power of Customized Medications in Dermatology: A Conversation with Dr. Steven Kolenik
SKNV Rx Insights The Power of Customized Medications in Dermatology: A Conversation with Dr. Steven Kolenik By Nathalie de Champlain, Chief Marketing Officer, SKNV As dermatology continues to evolve, the power of customization brings an incredible experience for dermatologists, providers, and patients. Our mission at SKNV is not only to improve patient outcomes but also […]